Description
+ Include: 62(+ 4) videos + 62(+ 4) file sub vtt + 53 pdfs, size: 18.58 (+ 66.94) GB
+ Target Audience: infectious disease physicians, internists, hospital medicine physicians, family practice physicians, pulmonologists, critical care medicine physicians, emergency medicine physicians
+ Sample video: contact me for sample video
+ Information:
1. Overview
The Harvard Infectious Diseases In Adults 2026 program provides a comprehensive, expert-led review of the most current developments in diagnosing and managing complex infectious diseases. The curriculum covers a wide array of high-yield topics, including antimicrobial stewardship, emerging fungal and viral infections, HIV management, and multidisciplinary approaches to challenging cases such as endocarditis, bone infections, and mycobacterial diseases.
Course Date: May 4, 2026 – May 8, 2026
Infectious Diseases in Adults 2026 provides state-of-the-art approaches for the prevention, diagnosis, and management of infectious diseases: common, challenging, rare, and emerging.
State-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases in Adults
Infectious Diseases in Adults 2026 is LIVE STREAMED with on-demand access available for 90 days after the course.
This comprehensive CME program, now in its 50th year, ensures attendees are current with state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases. Updates, best practices, and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results-driven:
- Optimal decision-making across a range of common and unusual infectious diseases
- Newer antimicrobials and treatment strategies for highly resistant infections
- Prevention and treatment of infections in immunocompromised hosts
- Update on antifungal diagnostics and therapy
- State-of-the-art and multidisciplinary approaches to common infections
- Clinical approaches to complex, rare, and “don’t-miss” infections
- New, evolving, emerging, and re-emerging infectious diseases
- Infections in persons with substance use disorder
- What’s new in HIV prevention and management
- The latest on COVID-19, including long COVID
- Adult vaccinations in 2026
As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.
In addition to being live streamed, all sessions will be recorded and placed in the online course library, enabling registrants to view them at their convenience. Recordings will be available for viewing for 90 days after the conclusion of the course. All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 60 days of the conclusion of the course to receive CME credit.)
Highlights of the 2026 Program
Expanded Case-Based and Problem-Solving Education
The 2026 program features an expanded range of interactive, case-based, and problem-solving education. The formats are engaging, and attendees are encouraged to pose questions to our national experts in live question-and-answer sessions following the lectures and the multidisciplinary workshops.
Our speakers and panelists include not only ID experts, but those from fields such as pharmacy, surgery, radiology, cardiology, pulmonology, and addiction medicine, thereby providing a 360-degree context for the understanding of ID treatment and patient care.
Our ten multidisciplinary workshops include complicated urinary tract and intra-abdominal infections, resistant Gram-positive and Gram-negative infections, management of endocarditis and cardiac device infections, musculoskeletal infections, and nontuberculous mycobacterial infections.
Treating Highly Resistant Infections, including:
- MRSA and VISA (vancomycin-intermediate Staph aureus)
- Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative rods
- Carbapenemase-producing Gram-negative rods, including NDM-1 metallo-beta-lactamase-producing organisms
- Vancomycin-resistant enterococci (VRE)
- Resistant fungal infections, including Aspergillus, other molds, and resistant Candidal infections
- Nontuberculous mycobacteria (NTM)
Common Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment, including:
- Respiratory viral infections, including COVID-19
- New and updated vaccine guidance
- Infections in the expanding populations of immunocompromised hosts
- Infections in persons with substance use disorder
- Infections of travelers and foreign-born persons
- Systemic fungal infections
- Native and device-related orthopedic infections
- Central nervous system (CNS) infections
- Native and prosthetic valve endocarditis, and cardiac device infections
- Ear, nose, and throat (ENT) and eye infections
- Skin and soft tissue infections
- Bronchiectasis and pneumonia
- HIV and its infectious and noninfectious complications
- PEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection
- Sexually transmitted infections (STIs), including mpox and PEP for prevention of STIs
- Hepatitis B and C infections
- Tick- and mosquito-borne infections
- Clostridioides difficile infection, the gut microbiome, and pre- and probiotics
- Complicated urinary tract infections
- Intra-abdominal infections
Challenging, Rare, and Emerging Infectious Diseases, including:
- Highly pathogenic avian flu
- Re-emergence of vaccine-preventable diseases, including poliomyelitis
- Pulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium abscessus
- Global infectious diseases of clinical importance
Clinical Decision-Making
Hear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:
- Selecting the best antimicrobial and duration of treatment
- Rapid detection and empiric treatment of life-threatening infectious diseases
- Choosing between inpatient and outpatient treatment, and between intravenous and oral antimicrobials
- Optimizing empiric antimicrobial therapy: what to start, and how and when to de-escalate
Our multidisciplinary talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:
- Antimicrobial stewardship to prevent resistance and reduce cost
- Early inpatient ID consultations to improve outcomes
- Strategies for management of infection in persons who inject drugs (PWID)
New in 2026: Advanced Learning Modules
- HIV
- Mycobacterial Infections
Each of these expanded learning modules provides advanced content for learners seeking to build additional expertise in these two important areas. These modules offer on-demand, self-paced lectures as well as live Meet-the-Professors sessions, where our expert faculty discuss cases submitted by our course participants.
2. Learning Objectives
- Utilize the latest strategies for the prevention, diagnosis, and management of important infectious disease syndromes in immunocompetent and immunocompromised patients
- Describe updated guidelines on the treatment of infectious diseases
- Summarize principles of judicious antimicrobial selection, dose, route, and duration to optimize patient outcomes while preventing resistance and lowering cost
- Describe evidence-based treatments as well as new treatment paradigms for resistant organisms and difficult-to-treat infections
- Recognize the role of novel, rapid diagnostics of infection and resistance in infectious disease practice
- Recognize the epidemiologic risk factors for emerging infectious diseases and provide optimal empiric and target therapies for infections
- Design and implement multidisciplinary care for patients in areas such as hematology oncology, solid organ transplantation, musculoskeletal infections, endocarditis, abdominal infections, and genitourinary infections
3. Target Audience
Best for infectious disease physicians and internists who want updates on antimicrobial stewardship, HIV, and managing complex infections.
Who Should Participate
Physicians, Nurse Practitioners, Physician Assistants, and Pharmacists in the fields of:
- Infectious Diseases
- Hospital Medicine
- Internal Medicine
- Family Practice
- Pulmonary and Critical Care Medicine
- Emergency Medicine
…and others who care for patients with infectious diseases
4. Topics
-
01 Advancing Patient Care Through Antimicrobial Stewardship
-
02 Update on Antifungal Diagnostics and Therapy
-
03 Plenary The Future of Global Public Health Lessons from HIV
-
04 Live Q&A Dr. Linda-Gail Bekker
-
05 Eye and ENT Infections What You Need to Know in 2026
-
06 Live Q&A Drs. Miriam Barshak, Nesli Basgoz, Alyssa Letourneau, and Michael Mansour
-
07 Multidisciplinary Panel Workshop 1 Resistant Gram-Positive Infections
-
08 Multidisciplinary Panel Workshop 2 Resistant Gram-Negative Infections
-
09 Live Q&A Drs. Alyssa Letourneau, Roby Bhattacharyya, Cecilia Li, and Tiffany Wu
-
10 C. difficile Update, the Gut Microbiome, and Pre- and Probiotics
-
11 Skin and Soft Tissue Infections Current Best Practices for Clinicians
-
12 Live Q&A Drs. Sandra Nelson and Elizabeth Hohmann
-
13 Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy
-
14 Infections in Hematologic Malignancies and Stem Cell Transplantation
-
15 Flummoxing Cases in Fungal Infections
-
16 Live Q&A Drs. Camille Kotton, Michael Mansour, Sarah Hammond, and Sarah Turbett
-
17 State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections
-
18 Updates on COVID-19, Including Long COVID
-
19 Navigating New Vaccines Updates and Recommendations
-
20 Pre- and Post-Exposure Prophylaxis for HIV and STIs
-
21 What’s New in the Care of People with HIV in 2026
-
22 Addressing the Continuing Challenges in HIV-Associated Opportunistic Infections
-
23 Live Q&A Drs. Rajesh Gandhi, Nesli Basgoz, Kevin Ard, and Camille Kotton
-
24 Self-Paced Study HIV Perinatal HIV Infection
-
25 Self-Paced Study HIV Perinatal Metabolic Complications of HIV
-
26 Self-Paced Study HIV Perinatal CROI Updates
-
27 Self-Paced Study HIV Perinatal HIV Resistance
-
28 Introduction to TB, Latent TB Infection, and Drug-Susceptible TB
-
29 Drug-Resistant TB and TB in Special Populations
-
30 Live Q&A Drs. Rocio Hurtado and Jodian Pinkney
-
31 Bronchiectasis and NTM Infections Anatomic and Clinical Approaches
-
32 The Latest on Major Respiratory Viral Infections
-
33 Innovations in HBV and HCV Care Updates for 2026
-
34 Live Q&A Drs. Nesli Basgoz, Arthur Kim, and Michael Ison
-
35 Live New England Journal of Medicine Clinicopathologic Conference (CPC) Please note This event will not be recorded
-
36 Clinical Challenges in Tropical Medicine A 2026 Review
-
37 Global Infectious Diseases Case-Based Updates
-
38 Live Q&A Dr. Edward T. Ryan
-
39 Multidisciplinary Panel Workshop 3 Management of Complex Nontuberculous Mycobacterial Infection (NTM) Pulmonary
-
40 Multidisciplinary Panel Workshop 4 Management of Complex Nontuberculous Mycobacterial Infection (NTM) Extrapulmonary
-
41 Live Q&A Drs. Rocio Hurtado, Michael Lanuti, Christopher Richards, Kristen Hysell, Alex Rock, and Alyssa Letourneau
-
42 Encephalitis and Meningitis Guidelines and Best Practices
-
43 Tick Talk Lyme Disease, Ehrlichia, Anaplasma, Babesia, and Rickettsia
-
44 Live Q&A Drs. Allan Tunkel and Kimon Zachary
-
45 Bone and Joint infections A Conceptual Framework
-
46 Staphylococcus aureus Déjà Vu All Over Again
-
47 Live Q&A Drs. Sandra Nelson and Henry Chambers
-
48 Multidisciplinary Panel Workshop 5 Native Bone Infections
-
49 Multidisciplinary Panel Workshop 6 Orthopedic Device Infections Prosthetic Joint Infections
-
50 Live Q&A Drs. Sandra Nelson, Hayden Box, F. Joseph Simeone, and Jeremy Goverman VIDEO NOT RELEASE
-
51 New and Emerging Viruses Clinical Insights for Frontline Providers and ID Specialists
-
52 KEYNOTE Polio The Unfinished Story
-
53 Live Q&A Drs. Martin Hirsch and David Oshinsky VIDEO NOT RELEASE
-
54 Intra-abdominal Infections A Conceptual Framework
-
55 Urinary Tract Infections A Conceptual Framework
-
56 Critical Care ID and Sepsis for the ID Clinician
-
57 Live Q&A Drs. Nesli Basgoz, Jacob Lazarus, and Lisa Bebell VIDEO NOT RELEASE
-
58 Multidisciplinary Workshop 7 Management of Complex Intra-abdominal Infections
-
59 Multidisciplinary Workshop 8 Management of Complex Urinary Tract Infections
-
60 Live Q&A Drs. Nesli Basgoz, Jacob Lazarus, Peter Fagenholz, Vincent Wu, Kristen Hung, and Lori Jones
-
61 Endocarditis and Cardiac Device Infections
-
62 The Syndemic of SUD and Infection Updated Approaches for 2026
-
63 Live Q&A Drs. Molly Paras and Jennifer Johnson
-
64 Multidisciplinary Workshop 9 Management of Endocarditis
-
65 Multidisciplinary Workshop 10 Management of Cardiac Device Infections
-
66 Live Q&A Drs. Molly Paras, Anne Duckles, Arminder Jassar, Shaan Khurshid, and Evin Yucel
Reviews
There are no reviews yet.